Germany-based CERTANIA secures investment from Summit Partners to drive global expansion
Germany-based provider of Testing, Inspection and Certification (TIC) services CERTANIA Holding GmbH has secured an investment boost from Summit Partners.
Popular topics
Health technology, digital therapeutics, biotech, and the slow remaking of medical practice through software and devices.
705 articles · Health Tech & Medtech
Germany-based provider of Testing, Inspection and Certification (TIC) services CERTANIA Holding GmbH has secured an investment boost from Summit Partners.
Tallinn, Harjumaa-based Siena Secondary Fund, an investment fund, announced on Wednesday, August 23, that it has made its first deal in Finland by acquiring a stake in Oura Ring, a sleep-tracking healthtech company.
Copenhagen-based Embla, a digital weight management clinic, announced on Wednesday that it has secured €10M in a Series A round of…
DrugCards, a Ukrainian medtech startup, secures funding from New Nordic Ventures for innovative pharmaceutical safety insights.
London-based biotech company Genomes.io has secured €18m funding commitment from GEM Digital Limited to enhance genomic data monetisation.
In a first, Lausanne, Switzerland-based medical device company Comphya announced on Monday the successful implantation of a high-tech, battery-powered device to restore erectile function.
Startup Lindus Health secures €16.56M in series A funding for transformative healthcare innovation.
Edinburgh, Scotland-based BDD, an integrated company that specialises in drug formulation and clinical trials, announced on Wednesday that it has raised £2M (approximately €2.3M) in funding.
Eindhoven-based Xeltis, a clinical-stage MedTech company, announced on Monday, August 14, that it has secured €12.5M in funding from the…
Zürich-based biotechnology company ZuriMED has successfully raised €15m through a Series A funding round.
Post-ICU secures a €1 million investment to drive its expansion and advancement in the USA.
Bactolife has secured over €30M in a Series A funding cycle to bring its exclusive Binding Proteins™ to market.